ArticleJACC. Basic to translational science2021

Rivaroxaban, a Direct Oral Factor Xa Inhibitor, Attenuates Atherosclerosis by Alleviating Factor Xa-PAR2-Mediated Autophagy Suppression.

Yusuke Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.